TOKYO
,
August 31, 2022
(press release)
–
Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) today announced plans to bolster capacity at its Singapore-based wholly owned subsidiary MITSUI ELASTOMERS SINGAPORE PTE LTD (MELS; President: NITTA Toshio) by building a new plant to produce the high-performance elastomer TAFMER™. Overview of new project TAFMER™ is used both as a soft molding material and as a resin modifier that dramatically improves resin properties. Its flexibility and lightness have resulted in TAFMER™ being used across a wide range of fields, including solar cell components, packaging materials, engineering plastic modifiers, sports shoes and automotive parts. Demand for TAFMER™ is strong amid robust global economic growth, and is expected to rise further on the back of efforts to achieve a circular economy and step up the introduction of clean energy. Via the supply of TAFMER™, which meets these needs, Mitsui Chemicals aims to become a global solutions company that leads change and contributes to the sustainable societies of the future. Overview of MELS
Product
TAFMER™ high-performance elastomer
Plant site
Jurong Island, Singapore
Capacity
120,000 tons/year
(Capacity of existing facility: 225,000 tons/year)
Schedule
Scheduled for completion sometime in fiscal 2024
As part of its new Long-Term Business Plan, VISION 2030, Mitsui Chemicals aims to help solve social challenges and achieve sustainable business growth by providing unique materials, features and services.
Company name
MITSUI ELASTOMERS SINGAPORE PTE LTD
Head office
3 HarbourFront Place #10-01 HarbourFront Tower 2
Singapore 099254, Singapore
Established
February 7, 2001
Capital
US$96.3 million (wholly owned by Mitsui Chemicals, Inc.)
Managing Director
NITTA Toshio
Business
Manufacture and sale of elastomers, primarily TAFMER™
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
